| Literature DB >> 25874893 |
Toshitsugu Fujita1, Miyuki Yuno1, Daisuke Okuzaki2, Rieko Ohki3, Hodaka Fujii1.
Abstract
Accumulating evidence suggests that RNAs interacting with genomic regions play important roles in the regulation of genome functions, including X chromosome inactivation and gene expression. However, to our knowledge, no non-biased methods of identifying RNAs that interact with a specific genomic region have been reported. Here, we used enChIP-RNA-Seq, a combination of engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) and RNA sequencing (RNA-Seq), to perform a non-biased search for RNAs interacting with telomeres. In enChIP-RNA-Seq, the target genomic regions are captured using an engineered DNA-binding molecule such as a transcription activator-like protein. Subsequently, RNAs that interact with the target genomic regions are purified and sequenced. The RNAs detected by enChIP-RNA-Seq contained known telomere-binding RNAs, including the telomerase RNA component (Terc), the RNA component of mitochondrial RNA processing endoribonuclease (Rmrp), and Cajal body-specific RNAs. In addition, a number of novel telomere-binding non-coding RNAs were also identified. Binding of two candidate non-coding RNAs to telomeres was confirmed by immunofluorescence microscopy and RNA fluorescence in situ hybridization (RNA-FISH) analyses. The novel telomere-binding non-coding RNAs identified here may play important roles in telomere functions. To our knowledge, this study is the first non-biased identification of RNAs associated with specific genomic regions. The results presented here suggest that enChIP-RNA-Seq analyses are useful for the identification of RNAs interacting with specific genomic regions, and may help to contribute to current understanding of the regulation of genome functions.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25874893 PMCID: PMC4395285 DOI: 10.1371/journal.pone.0123387
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Overview of the enChIP-RNA-Seq analysis.
(A, B) The enChIP-RNA-Seq system comprises a fusion molecule consisting of a tag(s), a nuclear localization signal (NLS), and an engineered DNA-binding molecule such as a transcription activator-like (TAL) protein, which recognizes endogenous target DNA sequences. The 3xFN-TAL protein comprising a 3xFLAG-tag, an NLS, and a TAL protein recognizing the target sequence is an example of the fusion molecule. (C) The 3xFN-TAL protein is expressed in a cell. If necessary, the sample is crosslinked with formaldehyde or another crosslinker, and then the chromatin is fragmented by sonication, enzymatic digestion, or another method. The chromatin complexes are purified by immunoprecipitation with an anti-FLAG Ab. Subsequently, the crosslinking is reversed (if required) and RNAs are purified and subjected to RNA-Seq.
Examples of RNAs associated with telomeres identified by enChIP-RNA-Seq.
| Categories | RNAs |
|---|---|
| Telomerase components |
|
| Telomeric RNAs | TERRAs |
| scaRNAs |
|
| H/ACA snoRNAs |
|
| C/D snoRNAs |
|
| lncRNA |
|
Fig 2Detection of TERRAs as RNAs associated with telomeres by enChIP-RNA-Seq.
(A) The numbers of TERRA transcripts in the negative control (3xFNLDD) and 3xFN-Tel-TAL enChIP-RNA-Seq samples. (B) Mapping of TERRA transcripts at a telomeric region in chromosome 18.
Telomere-enriched lncRNAs detected by enChIP-RNA-Seq.
| Chromosomal location (mm9) | Strand | Length (base) | Covered probe (ID) | Ensembl /NONCODEv3 ID | NONCODEv4 ID | Log2 ratio (telomere / negative control) |
|---|---|---|---|---|---|---|
| chr16:4871450–4874336 | Reverse | 2,887 | A_30_P01027969, A_30_P01023954, A_30_P01020286 | n278024, n285321, n288599 | NONMMUT030614, NONMMUT030615 | 3.084 |
| chr2:156213799–156216885 | Reverse | 3,087 | A_30_P01019211, A_30_P01022011, A_30_P01026195 | n414189, n263684 | NONMMUT040754 | 2.477 |
| chr18:13114368–13118513 | Forward | 4,146 | A_30_P01017429, A_30_P01031244, A_30_P01017747 | N.A. | N.A. | 2.430 |
| chrX:90997596–91009570 | N.D. | 11,975 | A_30_P01022594, A_30_P01028927, A_30_P01027891, A_30_P01021513, A_30_P01032697, A_30_P01025876, A_30_P01022054, A_30_P01029616, A_30_P01031912, A_30_P01028449, A_30_P01031411, A_30_P01027235, A_30_P01018764, A_30_P01024096, A_30_P01018317, A_30_P01029941, A_30_P01032299, A_30_P01032782, A_30_P01020940 | N.A. | NONMMUT090858 | 2.283 |
| chrX:91000652–91005855 | Reverse | 5,204 | A_30_P01033041, A_30_P01020922 | N.A. | NONMMUT090858 | 2.145 |
| chrX:11684505–11685304 | Forward | 800 | A_30_P01020753, A_30_P01022354, A_30_P01031956 | ENSMUST00000043441, ENSMUST00000145872, ENSMUST00000123004 | N.A. | 2.145 |
| chrX:18734107–18744367 | Reverse | 10,261 | A_30_P01020672, A_30_P01027310, A_30_P01027623 | n422780 | NONMMUT089161, NONMMUT089160 | 2.101 |
| chr6:31233513–31241062 | N.D. | 7,550 | A_30_P01024814, A_30_P01030148, A_30_P01025627, A_30_P01022038 | n413169, n421246, n412834, n295685, n412488, n412294, n412483, n416153, n412534, n413041, n413072, n411907, n416150, n416152, n423751, n416151, n421247, n412736, n412401 | NONMMUT069481 | 2.020 |
| chr2:153325671–153352170 | N.D. | 26,500 | A_30_P01021821, A_30_P01031381 | ENSMUST00000035346 | N.A. | 1.463 |
| chr6:83368262–83407280 | Reverse | 39,019 | A_30_P01023363, A_30_P01027012, A_30_P01026288, A_30_P01024889, A_30_P01026790, A_30_P01019688, A_30_P01020253, A_30_P01032016, A_30_P01030413, A_30_P01022314 | n268007 | NONMMUT071136, NONMMUT071138, NONMMUT071139, NONMMUT071141, NONMMUT071140 | 1.369 |
N.A., not available. N.D., not determined.
Fig 3Localization of candidate RNAs at telomeres.
Localization of SNORD17 (A) and NEAT1 (B) at telomeres in human U-2 OS cells. Cells were fixed and sequentially incubated with Abs against TRF-2 and AlexaFluor 488-conjugated anti-mouse IgG. Subsequently, the cells were hybridized with the RNA probes and subjected to fluorescence microscopy. Three different cells are shown.